Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
about
sameAs
The reticulons: a family of proteins with diverse functionsTissue specificity and regulation of the N-terminal diversity of reticulon 3Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsThe complex molecular biology of amyotrophic lateral sclerosis (ALS)ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the diseaseSafety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialOzanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsiesSerum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients.The expression patterns of Nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension: the expression of myelin proteins in the retina in glaucoma.Amyotrophic lateral sclerosis: a focus on disease progressionGenetic biomarkers for ALS disease in transgenic SOD1(G93A) miceMechanisms, models and biomarkers in amyotrophic lateral sclerosisThe neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis modelBiomarkers for amyotrophic lateral sclerosis.Amyotrophic lateral sclerosis: all roads lead to Rome.Use of biomarkers in ALS drug development and clinical trialsSkeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis.Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons.Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.Developmental Wiring of Specific Neurons Is Regulated by RET-1/Nogo-A in Caenorhabditis elegans.Species-dependent neuropathology in transgenic SOD1 pigs.The Nogo-66 receptor family in the intact and diseased CNS.The role of Nogo-A in axonal plasticity, regrowth and repair.Ventilatory control in ALS.New therapy options for amyotrophic lateral sclerosis.The role of reticulons in neurodegenerative diseases.Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.Mechanisms controlling neuromuscular junction stability.Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.New Insights into the Roles of Nogo-A in CNS Biology and Diseases.Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients.Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis.Nogo-A marks motor neuron disease.A common functional allele of the Nogo receptor gene, reticulon 4 receptor (RTN4R), is associated with sporadic amyotrophic lateral sclerosis in a French population.Changes of Nogo-A and receptor NgR in the lumbar spinal cord of ALS model mice.Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols.Nogo A expression in the adult enteric nervous system.Synaptic Failure: Focus in an Integrative View of ALS.
P2860
Q21184131-346DDF0E-6406-4646-84A5-B5EC975CA4E5Q24528150-84806103-AAB9-4176-9CF6-82ABC6556F4AQ27021917-80C5342C-CF03-4E76-A93C-A83935F1227FQ28263899-AA6D2841-DC6E-4194-917A-1F99ED3172B2Q28392297-89EF20EB-FCD7-41BE-9F70-72F7A4F1F194Q28538939-017F80DD-2C4F-4864-9B0C-87042858A8E2Q28543591-0893C6EC-2EA9-48AF-BCBA-E84B6DB4CDF8Q33741393-331BEA26-08DF-4FBF-B1B2-1BDEA038DDD8Q33924046-72A1E2C8-9920-44AD-B04C-57A1B3AC2636Q34064143-FBBD1858-2463-45FF-BD8C-1EF8DDEE2D18Q34193281-961021E0-A16D-43E2-9641-A9BB5AC4AA4AQ34344992-748CAB95-E9BF-464C-A9F4-D36935446CA4Q35191180-8211C5EE-5B59-4A4C-BB81-65359A89D9DDQ36481118-D2E04DF2-7467-4D31-A33E-069A60E59CA8Q36717512-7DB93DCA-80CA-4083-9205-E9BE55D5182CQ36733981-5599991F-56C9-4EC2-8406-73D90E5C8180Q36805205-27EEB7FB-8D6F-4F87-8892-3C69C33755E2Q37141293-32A54C9E-4EB4-47D6-B8CF-A3FA147B4568Q37165781-BE65F531-D0C4-447D-ADBE-5CAB6BB7455CQ37285915-94A97185-FE84-4738-BB3D-395C2B03EF1AQ37523903-FC5D434F-DDF3-4082-992F-B1FEFC9B2B81Q37576470-A65AC2B5-1D19-4DA4-A0D0-C809FA56F28AQ37684257-9AA580B4-7923-4512-961A-1653BE402CFDQ37981918-7F041031-7491-4348-8AE8-63B78B9E7F0BQ38010337-47A4B659-487D-4D13-A193-E8A7EADCB52FQ38108422-1E3D2C59-AB6E-48FE-A0D9-544150518FD8Q38121637-3EC017FA-1B4B-4F3A-B89C-3CA8140A9C07Q38161870-38B618BA-B751-44FE-B547-0F5179FEFAA0Q38223292-48915275-C344-4FBC-B61F-6A156C296F4BQ38264058-14090A4C-72C2-4191-8B50-69D8C6174E16Q38518708-3C6C3378-8927-4E64-AAF7-9AC7AB353810Q38565299-04FEB57B-8F3D-474C-B1DF-82BE9DAA4AEDQ39760999-C6AD3DDA-BBBE-4859-B5CE-0E2BDC551E4AQ42948005-F12A721D-4119-49F3-A8DE-8230A9A7C9E5Q43151954-EDEC9D1C-59AB-4197-9A00-E3E6FEE4CC2CQ48124421-B4B257DB-BCF2-45F1-A555-2734A8797B98Q48725884-F8190195-38B3-4FFC-8EF8-4D36B4281C0AQ49365640-2B066560-5C78-4D0B-B308-C6BE34DAB395Q53636144-D09B346F-D514-4361-9448-E0188FEC5951Q55233896-8166E217-15A5-474C-BB27-0B85CDB3DC4D
P2860
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@ast
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@en
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@nl
type
label
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@ast
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@en
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@nl
prefLabel
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@ast
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@en
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@nl
P2093
P356
P1476
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
@en
P2093
Danielle Seihlan
Franck di Scala
Frank S Walsh
Frédérique Rene
Jean-Philippe Loeffler
Jose-Luis Gonzalez de Aguilar
Luc Dupuis
Lucette Lacomblez
Marc de Tapia
Rabinder Prinjha
P304
P356
10.1006/NBDI.2002.0522
P407
P577
2002-08-01T00:00:00Z